DCN, as the small leucine-rich proteoglycan (SLRP) family class I member, always serves as the ligand of receptor tyrosine kinases to restrict tumor proliferation (Santra et al., 2000) or modulate tumor angiogenesis signals (Järveläinen et al., 2015). This evidence concerns the gene NTRK1 and neoplasm.